Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01275365 · ClinicalTrials.gov registry record · Phase 3
Optimizing Protein Intake in Older Americans With Mobility Limitations
A Phase 3 study of Mobility Limitation, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT01275365: Completed Phase 3 study of Mobility Limitation, sponsored by Brigham and Women's Hospital.
NCT01275365 is a Phase 3 study of Mobility Limitation that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 92 participants, below the 253-participant average among 28 other Mobility Limitation trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01275365, a Phase 3 study of Mobility Limitation, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, placebo-controlled, parallel group, double blind, clinical trial in community dwelling, older men, 65 years of age or older, who have mobility limitation and low protein intake. The study will have a 2 X 2 factorial design, which will allow us to investigate the effects of dietary protein intake and testosterone separately and together.
Primary Outcome
Primary outcome is change in lean body mass, measured by dual energy X-ray absorptiometry (DXA)
Conditions Studied
Interventions
- DRUG Testosterone enanthate
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-01-19 |
| Phase | Phase 3 |
What the finished NCT01275365 record still lists
NCT01275365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 253-participant average among 28 other Mobility Limitation trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 1 intervention - of which Testosterone enanthate is the first listed.
NCT01275365 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01275365 about?
NCT01275365 is a clinical study titled "Optimizing Protein Intake in Older Americans With Mobility Limitations". This will be a randomized, placebo-controlled, parallel group, double blind, clinical trial in community dwelling, older men, 65 years of age or older, who have mobility limitation and low protein intake. The study will have a 2 X 2 factorial design, which will allow us to investigate the effects of...
What is the current status of trial NCT01275365?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 92 participants. The study started on 2011-05. Estimated completion is 2017-01-19.
What conditions does trial NCT01275365 study?
This clinical trial studies the following conditions: Mobility Limitation.
What interventions are being tested in trial NCT01275365?
The interventions under investigation include: Testosterone enanthate (DRUG).
Who is sponsoring clinical trial NCT01275365?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01275365 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mobility Limitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01275365's enrollment target sits among peer trials
92 15th of 28 higher than 14 of 28 other Mobility Limitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
RECRUITING · Phase 2
-
Living Independence Through Functional Training
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia